+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glioma Treatment Market by Treatment Modality (Chemotherapy, Immunotherapy, Radiotherapy), Product Type (Branded, Generic), Glioma Grade, Line Of Therapy, Molecular Subtype, Patient Age, End User - Global Forecast 2025-2030- Product Image
Glioma Treatment Market by Treatment Modality (Chemotherapy, Immunotherapy, Radiotherapy), Product Type (Branded, Generic), Glioma Grade, Line Of Therapy, Molecular Subtype, Patient Age, End User - Global Forecast 2025-2030- Product Image
Sale

Glioma Treatment Market by Treatment Modality (Chemotherapy, Immunotherapy, Radiotherapy), Product Type (Branded, Generic), Glioma Grade, Line Of Therapy, Molecular Subtype, Patient Age, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968146
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers navigating the glioma treatment sector face a rapidly advancing market defined by scientific innovation, evolving regulatory strategies, and fresh operational and reimbursement challenges. Success now hinges on agility, data-driven decisions, and a holistic understanding of patient segments and regional landscapes.

Market Snapshot: Glioma Treatment Market

The global glioma treatment market grew from USD 5.29 billion in 2024 to USD 5.70 billion in 2025. With a projected CAGR of 7.53%, the sector is expected to reach USD 8.19 billion by 2030. This expansion reflects a collective shift towards advanced therapeutic strategies, robust R&D investments, and greater integration of precision medicine, intensifying competition and fostering rapid innovation aimed at improving patient outcomes and market differentiation.

Scope & Segmentation

This report comprehensively analyzes the entire glioma treatment continuum, providing stakeholders with detailed intelligence on market structure, technology uptake, and key players. Segmentation covers:

  • Treatment Modalities: Chemotherapy (alkylating agents, anti-microtubule agents), Immunotherapy (CAR T-cell therapy, checkpoint inhibitors, vaccines), Radiotherapy (brachytherapy, external beam), Surgery, Targeted Therapy (EGFR, VEGF inhibitors)
  • Product Types: Branded (biologics, small molecules), Generic (biologics, small molecules)
  • Glioma Grades: High grade (anaplastic astrocytoma, glioblastoma multiforme), Low grade (diffuse astrocytoma, oligoastrocytoma, oligodendroglioma)
  • Line of Therapy: First, second, and third-line interventions
  • Molecular Subtypes: IDH mutant and wildtype, MGMT methylation status
  • Patient Age Segments: Adult (18-64, 65+), Pediatric (adolescents 13-17, children 0-12)
  • End Users: Ambulatory surgical centers, cancer research institutes, clinics, hospitals
  • Geographies Covered: Americas (US, Canada, Mexico, Brazil, Argentina and state-level analysis), Europe, Middle East & Africa (including the UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and others)
  • Companies Profiled: F. Hoffmann-La Roche AG, Merck & Co., Inc., Novocure Ltd., Bristol-Myers Squibb Company, Eisai Co., Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Pfizer Inc., Novartis AG, Johnson & Johnson

Key Takeaways for Senior Decision-Makers

  • Precision medicine and molecular diagnostics are increasingly crucial for patient stratification and optimizing therapy selection, driving investment in sequencing and biomarker platforms.
  • Collaboration between pharmaceutical, biotechnology, and diagnostic firms is accelerating translational research, supporting more adaptive, real-world evidence-based clinical approaches.
  • Advanced manufacturing capabilities and regional partnerships reduce supply chain vulnerabilities, especially in response to changing import duties and operational risks.
  • Immune-based therapies, such as CAR T-cell approaches and checkpoint inhibitors, are broadening the treatment landscape, while incremental innovation in radiotherapy and surgery expands local control options.
  • Distinct regional dynamics—ranging from rapid biotech expansion in Asia-Pacific to technology transfer in Middle East and Africa—require market entry and pricing strategies calibrated to local infrastructure and regulation.
  • Portfolio diversification remains essential, with value-based evidence generation necessary for payer negotiations and sustained commercial advantage in both established and emerging markets.

Impact of US Tariffs on Supply Chain and Reimbursement

New US tariffs implemented in 2025 have increased costs for imported pharmaceutical ingredients and diagnostic equipment. This has led to revised supply chain strategies, with companies prioritizing domestic partnerships, renegotiating agreements, and reevaluating vendor relationships to manage cost pressures and ensure product flow. Payer-provider negotiations now increasingly focus on demonstrating health economics value and justifying reimbursement positions amid these financial shifts.

Research Methodology & Data Sources

This analysis employs a hybrid approach, combining an extensive review of peer-reviewed research, regulatory filings, policy documents, and clinical trial data with targeted interviews involving clinicians, economists, and supply chain experts. Triangulation methodologies and cross-referencing with patient registries strengthen reliability and ensure actionable insights for decision-makers.

Why This Report Matters

  • Equips executives with strategic intelligence to anticipate market shifts and proactively invest in future-ready innovations.
  • Supports resource optimization and robust market entry through unparalleled depth in segmentation and competitive benchmarking.
  • Facilitates more informed partner selection, portfolio development, and regional strategy decisions, based on real-world operational and segment-specific nuances.

Conclusion

The glioma treatment market is entering a phase of precision-driven growth shaped by technological, regulatory, and geographic change. Senior leaders equipped with these insights can drive portfolio impact and secure long-term competitive positioning in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of tumor treating fields technology as an adjunct to chemotherapy and radiotherapy
5.2. Increasing investment in personalized neoantigen vaccine research for recurrent glioblastoma patients
5.3. Breakthrough development of blood-brain barrier penetrating nanoparticles for targeted drug delivery
5.4. Emergence of digital pathology and AI-powered imaging platforms optimizing glioma diagnosis and grading accuracy
5.5. Rising approvals of intraoperative MRI systems to enhance surgical precision in glioma resections
5.6. Expansion of clinical trials exploring novel IDH inhibitors for treatment of low grade gliomas
5.7. Strategic partnerships between biotech firms and academic centers accelerating glioma immunotherapy pipelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glioma Treatment Market, by Treatment Modality
8.1. Introduction
8.2. Chemotherapy
8.2.1. Alkylating Agents
8.2.2. Anti-Microtubule Agents
8.3. Immunotherapy
8.3.1. Car T-Cell Therapy
8.3.2. Checkpoint Inhibitors
8.3.3. Vaccines
8.4. Radiotherapy
8.4.1. Brachytherapy
8.4.2. External Beam Radiotherapy
8.5. Surgery
8.6. Targeted Therapy
8.6.1. Egfr Inhibitors
8.6.2. Vegf Inhibitors
9. Glioma Treatment Market, by Product Type
9.1. Introduction
9.2. Branded
9.2.1. Biologics
9.2.2. Small Molecule
9.3. Generic
9.3.1. Biologics
9.3.2. Small Molecule
10. Glioma Treatment Market, by Glioma Grade
10.1. Introduction
10.2. High Grade
10.2.1. Anaplastic Astrocytoma
10.2.2. Glioblastoma Multiforme
10.3. Low Grade
10.3.1. Diffuse Astrocytoma
10.3.2. Oligoastrocytoma
10.3.3. Oligodendroglioma
11. Glioma Treatment Market, by Line Of Therapy
11.1. Introduction
11.2. First Line
11.3. Second Line
11.4. Third Line
12. Glioma Treatment Market, by Molecular Subtype
12.1. Introduction
12.2. Idh Mutant
12.3. Idh Wildtype
12.4. Mgmt Methylation Positive
12.5. Mgmt Unmethylated
13. Glioma Treatment Market, by Patient Age
13.1. Introduction
13.2. Adult
13.2.1. 18-64
13.2.2. 65+
13.3. Pediatric
13.3.1. Adolescents 13-17
13.3.2. Children 0-12
14. Glioma Treatment Market, by End User
14.1. Introduction
14.2. Ambulatory Surgical Centers
14.3. Cancer Research Institutes
14.4. Clinics
14.5. Hospitals
15. Americas Glioma Treatment Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Glioma Treatment Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Glioma Treatment Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. F. Hoffmann-La Roche AG
18.3.2. Merck & Co., Inc.
18.3.3. Novocure Ltd.
18.3.4. Bristol-Myers Squibb Company
18.3.5. Eisai Co., Ltd.
18.3.6. Teva Pharmaceutical Industries Ltd.
18.3.7. Dr. Reddy’s Laboratories Ltd.
18.3.8. Pfizer Inc.
18.3.9. Novartis AG
18.3.10. Johnson & Johnson
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. GLIOMA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GLIOMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLIOMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. GLIOMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. GLIOMA TREATMENT MARKET: RESEARCHAI
FIGURE 30. GLIOMA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 31. GLIOMA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 32. GLIOMA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GLIOMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLIOMA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GLIOMA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ANTI-MICROTUBULE AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ANTI-MICROTUBULE AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CAR T-CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CAR T-CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY VEGF INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY VEGF INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ANAPLASTIC ASTROCYTOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ANAPLASTIC ASTROCYTOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY DIFFUSE ASTROCYTOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY DIFFUSE ASTROCYTOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY OLIGOASTROCYTOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY OLIGOASTROCYTOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY OLIGODENDROGLIOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY OLIGODENDROGLIOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IDH MUTANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IDH MUTANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IDH WILDTYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY IDH WILDTYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MGMT METHYLATION POSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MGMT METHYLATION POSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MGMT UNMETHYLATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY MGMT UNMETHYLATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY 18-64, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY 18-64, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY 65+, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY 65+, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ADOLESCENTS 13-17, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY ADOLESCENTS 13-17, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHILDREN 0-12, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CHILDREN 0-12, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GLIOMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS GLIOMA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES GLIOMA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 203. CANADA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 204. CANADA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 205. CANADA GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 206. CANADA GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 207. CANADA GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 208. CANADA GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 209. CANADA GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 210. CANADA GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 211. CANADA GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 212. CANADA GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 213. CANADA GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. CANADA GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 216. CANADA GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 217. CANADA GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 218. CANADA GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 219. CANADA GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 220. CANADA GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 221. CANADA GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 222. CANADA GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 223. CANADA GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 224. CANADA GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 225. CANADA GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 226. CANADA GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 227. CANADA GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 228. CANADA GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 229. CANADA GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 230. CANADA GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 231. CANADA GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 232. CANADA GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 233. CANADA GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 234. CANADA GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 235. CANADA GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. CANADA GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 246. MEXICO GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 247. MEXICO GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 250. MEXICO GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 251. MEXICO GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 252. MEXICO GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 253. MEXICO GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 260. MEXICO GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 261. MEXICO GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 266. MEXICO GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 267. MEXICO GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 268. MEXICO GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 269. MEXICO GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. MEXICO GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY GLIOMA GRADE, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY HIGH GRADE, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY LOW GRADE, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY MOLECULAR SUBTYPE, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA GLIOMA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA GLIOMA TREATMENT MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Glioma Treatment market report include:
  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Novocure Ltd.
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.19 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Glioma Treatment - Global Strategic Business Report - Product Image

Glioma Treatment - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Glioma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Glioma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Malignant Glioma Therapeutics - Global Strategic Business Report - Product Image

Malignant Glioma Therapeutics - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Adult Malignant Glioma Therapeutics Market Report 2025 - Product Image

Adult Malignant Glioma Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glioma Treatment Market Report 2025 - Product Image

Glioma Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Glioma Drug Market

The Glioma Drug market is a subset of the larger Brain Cancer Drug market. Glioma is a type of brain cancer that is caused by the abnormal growth of glial cells in the brain. Treatment for glioma typically involves surgery, radiation therapy, chemotherapy, and targeted therapy. Drugs used to treat glioma include temozolomide, bevacizumab, and lomustine. Glioma drugs are typically used in combination with other treatments, such as radiation and surgery, to improve patient outcomes. The market for glioma drugs is expected to grow due to the increasing prevalence of brain cancer and the development of new treatments. Some companies in the Glioma Drug market include Novartis, Merck, Roche, and Pfizer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.